|
Re: fascinating presentatio from ASCO--her2 on breast cancer stem cells and bc stem c
You had posted something along this line earlier, I think. It seems really good, since there seems to be multiple justifications for her2 therapy beyond progression.
It also supports the notion that short term scan measurements may not tell the whole story about treatment benefit.
|